GL Ucim V 1mg/500mg/0.2mg Tablet SR
Marketer
Trumac Healthcare
Salt Composition
Glimepiride (1mg) + Metformin (500mg) + Voglibose (0.2mg)
Overview GL Ucim V 1mg/500mg/0.2mg Tablet SR
Avelox-D 1mg/500mg/0.2mg extended-release tablets are classified as antidiabetic medications. This combination therapy treats type 2 diabetes in adults by helping regulate blood glucose. Avelox-D should be ingested with food, consistently at the same time daily for optimal effectiveness. Dosage is determined and adjusted by your physician based on your blood sugar response. Continued use is crucial, even with well-managed blood sugar, as discontinuation without medical supervision risks elevated glucose levels, potentially leading to kidney complications, vision impairment, neuropathy, and limb loss. This medication is part of a comprehensive diabetes management plan incorporating diet, exercise, and weight management as directed by your doctor. Lifestyle choices significantly impact diabetes control. Hypoglycemia (low blood sugar) is the most frequent side effect, manifested by sweating, dizziness, headache, and tremors. Regular meals and readily available glucose sources (e.g., sugary snacks, juice) are essential. Alcohol consumption should be minimized due to its potential to exacerbate hypoglycemia. Additional possible side effects include altered taste, nausea, diarrhea, abdominal discomfort, headache, edema, blurred vision, bone fractures, and upper respiratory infections. Weight gain may occur. This medication is contraindicated in individuals with type 1 diabetes, diabetic ketoacidosis, or severe hepatic or renal impairment. Prior heart disease should be disclosed to your physician before commencing treatment. Pregnant or lactating women require medical consultation before use. Regular blood glucose monitoring and periodic blood tests (complete blood count and liver function tests) are recommended.
Uses of GL Ucim V 1mg/500mg/0.2mg Tablet SR
Managing Type 2 Diabetes
Major Benefits of GL Ucim V 1mg/500mg/0.2mg Tablet SR:
Consume this medication precisely as directed by your physician, adhering to the prescribed dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. GL Ucim V 1mg/500mg/0.2mg Extended-Release Tablets should be administered on an empty stomach.
Common Side effects of GL Ucim V 1mg/500mg/0.2mg Tablet SR:
- Nausea
- Diarrhea
- Abdominal pain
- Hypoglycemia (low blood glucose level)
- Loss of appetite
How to use GL Ucim V 1mg/500mg/0.2mg Tablet SR:
Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment duration. Ingest the entire tablet without chewing, crushing, or breaking it. The GL Ucim V 1mg/500mg/0.2mg Extended-Release tablet should be taken on an empty stomach.
How GL Ucim V 1mg/500mg/0.2mg Tablet SR works:
Each GL Ucim V 1mg/500mg/0.2mg extended-release tablet combines three antidiabetic agents.
SAFETY ADVICE
AlcoholUNSAFE
Concurrent alcohol use with GL Ucim V 1mg/500mg/0.2mg SR tablets is contraindicated.
PregnancyCONSULT YOUR DOCTOR
The extended-release tablet GL Ucim V (1mg/500mg/0.2mg) might pose risks during pregnancy. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the advantages against possible dangers prior to prescribing it. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
The extended-release GL Ucim V 1mg/500mg/0.2mg tablet is likely not safe for breastfeeding mothers. Available human data indicates potential transfer to breast milk, posing a risk to the infant.
DrivingCAUTION
Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.
KidneyUNSAFE
The use of GL Ucim V 1mg/500mg/0.2mg Tablet SR is likely unsafe for individuals with kidney impairment and should be omitted. A physician's consultation is advised. Furthermore, this medication is contraindicated in patients exhibiting severe kidney dysfunction.
LiverCAUTION
Patients with liver impairment should use GL Ucim V 1mg/500mg/0.2mg SR tablets cautiously, potentially requiring dose modification. A physician's consultation is advised. In those with mild to moderate liver disease, initiation should be at a low dosage; its use is contraindicated in patients with severe hepatic dysfunction.
What if you forget to take GL Ucim V 1mg/500mg/0.2mg Tablet SR :
Should you forget to take a GL Ucim V 1mg/500mg/0.2mg Tablet SR, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About GL Ucim V 1mg/500mg/0.2mg Tablet SR
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Diabetes Management |
3,018 People bought this recently